US Stock MarketDetailed Quotes

PTCT PTC Therapeutics

Watchlist
  • 51.820
  • +2.150+4.33%
Close Feb 14 16:00 ET
  • 51.820
  • 0.0000.00%
Post 20:01 ET
4.00BMarket Cap-8.72P/E (TTM)

PTC Therapeutics Key Stats

PTC Therapeutics Q4 2024 Estimates Date

Currency:USDFeb 27, 2025

Estimate YoY
Revenue
248.99M
-18.91%
EPS
-0.43
+79.30%
Buy

Feb 12, 2025

PTC Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 445.937M--
Feb 27, 20252024/Q4-- / 248.994M--
Nov 7, 20242024/Q3196.786M / 171.804M--
Aug 8, 20242024/Q2186.704M / 181.013M--
Apr 25, 20242024/Q1210.118M / 163.823M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 445.937M--
Feb 27, 20252024/Q4-- / 248.994M--
Nov 7, 20242024/Q3196.786M / 171.804M--
Aug 8, 20242024/Q2186.704M / 181.013M--
Apr 25, 20242024/Q1210.118M / 163.823M--

Unlock Free Earnings Estimates

PTC Therapeutics Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 12, 2025

Buy

  • Buy

    57.14%
  • Hold

    21.43%
  • Sell

    21.43%

Price Target

No Data